Fluoroscopy and C-Arm Market Analysis & Forecast: 2025-2032

Fluoroscopy and C-Arm Market Size and Forecast – 2024 to 2031

The global fluoroscopy and C-Arm market is estimated to be valued at USD 4.10 Bn in 2024 and is expected to reach USD 5.71 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 4.8% from 2024 to 2031.

Key Takeaways of the Fluoroscopy and C-Arm Market:

• By type, the C-Arms segment is expected to contribute the highest share of the market with 52.1% in 2024
• By application, the cardiology segment is expected to contribute the highest share of the market with 23.1% in 2024
• By portability, the fixed systems segment is expected to contribute the highest share of the market with 51.1% in 2024
• North America is expected to top the global market with 37.3% share, followed by Asia Pacific with 25.2% share in 2024

Market Overview:

Advancements in medical imaging technologies and rising chronic disease prevalence are fueling demand for these devices globally. The rising elderly population and increasing road accidents and trauma cases also drive market revenue. The market is witnessing growing demand for fully-motorized C-arms as they provide better image quality and higher versatility compared to traditional C-arms. Features like flat panel detectors and high resolution are gaining popularity. Furthermore, the increasing consolidation among market players to improve product portfolio through mergers and acquisitions will define the competitive dynamics over the coming years.

Segmental Insights

To learn more about this report, Request sample copy

Type Insights - Advancing Imaging Quality and Precision Drives C-Arms Adoption

In terms of type, the C-Arms segment is expected to contribute the highest share of the fluoroscopy and C-Arm market with 52.1% in 2024 owing to continuous innovation in imaging technologies. C-Arms equipped with flat panel detectors and high-resolution imaging panels allow clinicians to obtain crystal clear fluoroscopy and angiography images. This high-quality imaging enables accurate diagnosis and treatment monitoring. The miniaturization of components has also made new generations of C-Arms highly portable and mobile within operating rooms and clinics. This enhanced mobility allows clinicians to perform a wide range of fluoroscopy-guided procedures across departments. Furthermore, new C-Arms integrate advanced 3D imaging and reconstruction capabilities. These 3D imaging tools provide surgeons deep tissue visibility and precise anatomical views during complex orthopedic and spine surgeries.

Application Insights - Cardiology Drives Demand Due to Rising Prevalence of Heart Diseases

In terms of application, the cardiology segment is expected to contribute the highest share of the market with 23.1% in 2024 owing to the growing prevalence of cardiovascular diseases globally. Conditions such as coronary artery disease, heart failure, and arrhythmias have significant morbidity and mortality. Fluoroscopy and C-Arm systems are invaluable tools for cardiologists to diagnose and treat these conditions. They are used for angiography, angioplasty, stent placement and a variety of ablation procedures. Given the rising economic costs of treating heart disease, there is increased emphasis on early detection as well as minimally invasive techniques.

Portability Insights - Ubiquity of Fixed Systems Spurs their Widespread Adoption

In terms of portability, the fixed systems segment is expected to contribute the highest share of the market with 51.1% in 2024 attributed to their accessibility and pervasiveness across healthcare facilities. Given high capital investments, most hospitals and clinics possess fixed fluoroscopy systems in interventional suites, cardiac catheterization labs and surgical theaters. This allows for continuous, seamless procedures without time constraints associated with repositioning or transferring mobile C-Arms. Fixed systems also offer premium imaging capabilities compatible with complex cardiovascular or neuroradiology cases.

Regional Insights

To learn more about this report, Request sample copy

North America Fluoroscopy and C-Arm Market Trends

North America is projected to dominate the fluoroscopy and C-arm industry with a 37.3% share in 2024, driven by its well-established healthcare infrastructure and access to advanced medical facilities. Moreover, favorable reimbursement policies have ensured higher adoption rates of new medical technologies. Major players in the region have also introduced advanced products, which has boosted market growth over the years.

Asia Pacific Fluoroscopy and C-Arm Market Trends

The Asia Pacific region exhibits the fastest growth, with a share of 25.2% in 2024 driven by rising medical tourism and growing healthcare expenditure in countries like China and India. Governments of emerging economies have implemented several initiatives to modernize their healthcare systems. Increasing investments by international brands have also expanded access to state-of-the-art medical devices.

Fluoroscopy and C-Arm Market Outlook for Key Countries

U.S. Fluoroscopy and C-Arm Market Trends

The growth of the U.S. fluoroscopy and C-arms market is significantly driven by the rising trend of new product approvals, launches, and advancements in technology. For example, in December 2022, MINICARM.COM, a medical device company, expanded its U.S. warehouse to include a high-quality Mini C-Arm refurbishment center. These Mini C-Arms are utilized for fluoroscopic imaging of extremities in orthopedic surgeries and digital diagnostic imaging.

U.K. Fluoroscopy and C-Arm Market Trends

The U.K. fluoroscopy and C-arm market is poised for growth, driven by the increasing prevalence of cardiovascular diseases. According to the BHF 2022 report, vascular dementia affected at least 150,000 people in the U.K. in 2022, with projections rising to 350,000 by 2030. Fluoroscopy is essential in cardiovascular procedures, providing precise spatial and temporal resolution for guiding endovascular catheters while minimizing radiation exposure.

India Fluoroscopy and C-Arm Market Trends

The increasing number of hospitals and clinics, along with advancements in healthcare infrastructure, is driving the adoption of technologically advanced C-arm systems, including digital C-arms. For example, in January 2020, India-based Trivitron Healthcare introduced the Elite Flat Panel Digital C-arm featuring motorized movements.

Brazil Fluoroscopy and C-Arm Market Trends

Brazil is witnessing growth in the fluoroscopy and C-arm market, supported by government initiatives to enhance healthcare access. In 2022, the Brazilian Ministry of Health launched a program to improve diagnostic imaging services in public hospitals, which is expected to boost the demand for fluoroscopy and C-arm systems.

Market Players, Key Devlopment, and Competitive Intelligence

Get actionable strategies to beat competition: Request sample copy

Key Developments:

• In November 2024, GE HealthCare, a global medical technology, introduced advanced imaging innovations for its OEC 3D mobile CBCT C-arm, enhancing precision and workflow in interventional pulmonology. The addition of the Lung Suite and expanded third-party data interface options streamline imaging during endoscopic bronchoscopy procedures, helping clinicians accurately locate and biopsy lung nodules despite challenges like respiratory pattern changes and CT-to-body divergence. These advancements aim to improve diagnostic confidence and efficiency in complex pulmonary and thoracic procedures.
• In November 2024, Augmedics, a developer of an augmented-reality surgical visualization system, announced the USFDA 510(k) clearance for its new CT-to-fluoroscopy (CT-Fluoro) registration method for the xvision Spine System, enabling AR navigation with preoperative CT scans and standard 2D C-arm images, eliminating the need for 3D intraoperative imaging. The first surgery using this method was successfully performed by Dr. Frank Phillips at Rush University Medical Center, highlighting its potential to expand AR navigation access for spine surgeons.
• In March 2024, Siemens Healthineers has received U.S. FDA clearance for the CIARTIC Move, a self-driving mobile C-arm that streamlines 2D fluoroscopic and 3D cone-beam CT imaging for surgeries. Designed for orthopedic, trauma, spine, and other procedures, it automates workflows, reduces imaging time, and supports overtaxed operating room teams. This innovation marks Siemens’ first self-driving mobile C-arm, enhancing efficiency in hospitals and outpatient facilities.
• In July 2022, FUJIFILM Healthcare Americas Corporation, a leading innovator in diagnostic and enterprise imaging solutions, launched the Flat Detector Radiography,FDR Cross in the U.S., an innovative hybrid C-arm and portable X-ray system designed for hospitals and ambulatory surgery centers. This dual-function system combines fluoroscopic and radiographic imaging on a single platform, streamlining workflows and improving patient care. According to Rob Fabrizio, the FDR Cross enhances equipment efficiency by enabling multiple imaging functions with one device.

Top Strategies Followed by global fluoroscopy and C-Arm market Players

• Established Players: Leading companies such as Siemens and GE Healthcare prioritize extensive research and development to innovate high-performance products.
  • For Instance, in December 2024, Siemens launched a new fluoroscopy system that incorporates advanced imaging technology, enhancing diagnostic accuracy and patient outcomes. This investment in R&D underscores its commitment to maintaining a competitive edge in the market.
• Mid-Level Players: Mid-level players focus on delivering quality, budget-friendly products targeting price-sensitive consumers.
  • For instance, in August 2022, Xoran Technologies received U.S. FDA 510(k) clearance for TRON, a mobile full-body fluoroscopy and CT X-ray system. Designed for compact settings like operating rooms and critical care units, TRON offers secure, ultra-high-resolution, low-dose imaging.
• Small-Scale Players: Small players leverage niche specialization to carve out space. Brainlab developed ExacTrac, a niche image-guided radiotherapy platform optimized for precise oncology treatments. Ziehm Imaging focuses on mobile C-arm solutions for use in surgery rooms, allowing freedom of movement during procedures.

Emerging Startups - Fluoroscopy and C-Arm Industry Ecosystem

• Innovative Technologies: Startups are exploring advanced technologies like Anthropic’s surgical vision system using AI to enhance surgical imaging. Boundary Layer uses smart sensor fusion for robotic precision and 3D imaging in its Explorer C-arm, improving operating room workflows.
• Sustainable Solutions: Echo360 Sustainable Imaging produces zero-waste desktop fluoroscopy machines made from recycled ocean plastics and electronic waste. Ambient Medical develops reusable, non-disposable covers and drapes made from rapidly renewable bamboo fiber, lowering environmental impact.
• Market Contribution: Startups often address underserved market areas. Peak Surgical developed the MolecuLight i:X, a handheld fluorescence imaging device for detecting bacteria in wounds, opening new clinical applications. Startups address unique market needs by developing specialized C-arm systems for specific procedures, such as orthopedic or dental surgeries.

Market Report Scope

Market Dynamics

Discover market dynamics shaping the industry: Request sample copy

Fluoroscopy and C-Arm Market Growth Factors - Increasing demand for minimally invasive surgical procedures

The worldwide healthcare sector has seen a significant rise in the preference for minimally invasive procedures over traditional open surgeries in the recent years. Minimally invasive surgeries are generally associated with reduced trauma, shorter hospital stays, and quicker recovery times for patients. This has led to growing adoption of such techniques across various therapeutic areas like cardiology, orthopedics, urology, and others. Fluoroscopy and C-arms are imaging modalities that play a vital role in enabling minimally invasive interventions. For instance, an article published in March 2022 in the BMC Journal highlighted that surgeons have greater confidence in minimally invasive techniques for straightforward procedures such as appendectomy, cholecystectomy, and abdominal exploration. Additionally, according to the WPP 2022, the global population aged 65 and above is expected to increase from 10% in 2022 to 16% by 2050.

Fluoroscopy and C-Arm Market Challenge - High costs associated with fluoroscopy and C-arm systems

The high costs associated with fluoroscopy and C-arm systems present a major challenge for the growth of the global market. These systems involve significant upfront capital expenditures and high maintenance costs throughout the product lifespan. The prices of premium C-arm systems can range from US$ 300,000 to US$ 500,000. Similarly, advanced fluoroscopy systems cost over US$ 200,000. The maintenance and service contracts for such systems add an extra 20-30% cost annually. This high total cost of ownership puts these advanced imaging technologies out of reach for many smaller healthcare facilities and hospitals in developing regions. T fluoroscopy and C-arm systems.

Fluoroscopy and C-Arm Market Opportunities - Growing adoption of AI and machine learning in imaging technologies for opportunities in the market

The growing adoption of artificial intelligence (AI) and machine learning capabilities in fluoroscopy and C-arm imaging presents significant opportunities for growth in the global market. AI-powered systems can automate routine tasks, enhance image quality, reduce errors and improve clinical outcomes. For example, machine learning algorithms are being used for automated dose management, noise reduction, and motion correction in real-time imaging. AI can also help detect anomalies or abnormalities unnoticed by humans. This will likely improve accuracy of diagnoses and treatment decisions. Further, AI-assisted imaging technologies can overcome staffing shortages and make premium capabilities more affordable for smaller hospitals.

Analyst Opinion (Expert Opinion)

• The global fluoroscopy and C-arm industry is expected to witness steady growth over the forecast period driven by the increasing prevalence of chronic diseases and rising demand for minimally invasive surgeries. The market will further benefit from the growing geriatric population who are more prone to orthopedic disorders. Technological advancements leading to the development of more portable and advanced C-arms with flat panel detectors and lower radiation dose will support market expansion. North America currently dominates the market owing to favorable reimbursement policies and rising healthcare expenditure in the region. Asia Pacific is expected to be the fastest growing regional market owing to growing medical tourism, improving healthcare infrastructure, and rising healthcare spending in China and India.
• High cost of fluoroscopy guided procedures, limited reimbursements, and lack of skilled physicians could restrict market growth to a certain extent. Stringent regulations pertaining to radiation emission from fluoroscopy devices also acts as a challenge for manufacturers. Moreover, advanced fluoroscopy systems have a long replacement cycle that could hamper frequent purchase of new systems. The market players could benefit by focusing on emerging countries in Asia Pacific and Latin America through tie-ups with local market players. Adoption of AI and augmented reality in fluoroscopy imaging offers new opportunities for growth in the long run.

Market Segmentation

• By Type Insights (Revenue, USD Bn, 2019 - 2031)
• • C-Arms
    • Mini C-Arms
    • Compact C-Arms
    • Full-Size C-Arms
  • Fluoroscopy Devices
• By Application Insights (Revenue, USD Bn, 2019 - 2031)
• • Cardiology
  • Gastroenterology
  • Neurology
  • Orthopedic and Trauma
  • Oncology
  • Others
• By Portability Insights (Revenue, USD Bn, 2019 - 2031)
• • Fixed Systems
  • Mobile Systems
• By End User Insights (Revenue, USD Bn, 2019 - 2031)
• • Hospitals
  • Clinics
  • Diagnostic Centers
  • Specialty Clinics
  • Ambulatory Surgical Centers
• Regional Insights (Revenue, USD Bn, 2019 - 2031)
• • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
• Key Players Insights
• • General Electric Company
  • Koninklijke Philips N.V.
  • Siemens Healthcare Private Limited
  • Canon Medical Systems Corporation
  • Shimadzu Corporation
  • Carestream Health
  • Hitachi, Ltd.
  • Hologic, Inc.
  • Varex Imaging Corporation
  • Ziehm Imaging GmbH
  • OrthoScan, Inc.
  • Varian Medical Systems, Inc.
  • DMS Group
  • ITALRAY
  • Nova Biomedical